Treace Medical Q1 net loss widens to $18 million; revenue drops 10% to $47.2 million

Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc.

TMCI

0.00
  • Treace Medical Concepts posted Q1 2026 revenue of USD 47.2 million, down 10%, while net loss widened to USD 18 million, or USD 0.28 per share.
  • Adjusted EBITDA loss widened to USD 5.5 million from USD 3.8 million.
  • Cash, cash equivalents, and marketable securities rose to USD 51.9 million at March 31, up USD 3.5 million from year-end, with an additional USD 115 million available under its credit facility subject to conditions.
  • Initiated a limited market release of SuperBite Compression Screw System, reporting successful first commercial cases, while granted patents surpassed 130 with more than 200 pending applications.
  • Reaffirmed full-year 2026 revenue guidance of USD 202 million to USD 212 million, projecting an adjusted EBITDA loss of USD 4 million to USD 6 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Treace Medical Concepts Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605080705PRIMZONEFULLFEED9716214) on May 08, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.